PFE Stock 12 Month Forecast $31.56 ▲(24.99% Upside) Based on19Wall Street analysts offering 12 month price targets forPfizerin the last3 months. The average price target is$31.56with a high forecast of$45.00and a low forecast of$25.00. The average price target represents a24.99%change from...
PFE Stock 12 Month Forecast All Analysts Top Analysts Average Price Target $31.56 ▲(24.99% Upside) High$45.00 Average$31.56 Low$25.00 Detailed Analyst Forecast > Similar Stocks Company Price & Change Follow MRK Merck & Company ― ― JNJ ...
Pfizer (PFE) adaptive stock price forecast & ideologically balanced news. Transparently evaluate AI model performance.
Stock report for PFE - Pfizer Inc including beta, volatilty estimates, value-at-risk, support and resistance levels, and moving averages.
9:54p Stitch Fix’s stock rallies after styling service boosts full-year sales forecast 8:45p Education Department to cut half of its workforce, raising doubts about its ability to function 7:53p Oracle won some big cloud contracts. Here’s why its stock is falling. 7:51p Verizon and ...
Explore Pfizer (PFE) dividend history, dividend yield range, next PFE dividend date, and Pfizer stock dividend forecast.
In January 2023, Pfizer forecast a steep drop in annual revenue, to between $67 billion and $71 billion. That outlook included $13.5 billion and $8 billion in sales of Covid vaccines and Paxlovid, respectively. But it could not predict at the time just how much revenue would dry up. ...
In August, Pfizer’s stock came under fire when the drug maker reported a drop in earnings because of weaker demand for COVID vaccines and antiviral drugs. Even with that lower demand, Pfizer forecast in August full-year earnings of $3.25 to $3.45 a share on revenue of $6...
What is Pfizer (PFE) stock EPS forecast? Pfizer beat analysts’ expectations during the last earnings period by 33.59%. Pfizer reported earnings of $ 0.63 per share on Feb 4, 2025, while the forecasted EPS was $ 0.4716. Your capital is at risk. Other fees may apply. Add to Watchl...
Pfizer, Inc. on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, driving shares down 9% to a 10-year low. December 6, 2023 Pfizer CEO slams presidents of elite colleges over ‘despicable’ antisemitism ...